Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Curanex Pharmaceuticals Inc (CURX) had Income from Continuous Operations of $-3.15M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-3.15M |
|
-- |
|
-- |
|
$3.18M |
|
$-3.18M |
|
$0.03M |
|
$-3.15M |
|
$-3.15M |
|
$-3.15M |
|
|
Income from Continuous Operations |
$-3.15M |
$-3.15M |
|
$-3.15M |
|
$-3.18M |
|
$-3.15M |
|
28.34M |
|
28.34M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$8.09M |
|
-- |
|
$0.32M |
|
$8.41M |
|
$0.13M |
|
-- |
|
$0.20M |
|
$0.33M |
|
$8.08M |
|
$8.08M |
|
$8.08M |
|
28.36M |
|
| Cash Flow Statement Financials | |
$-0.95M |
|
-- |
|
-- |
|
$4.97M |
|
$4.02M |
|
$-0.95M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
62.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.95M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-38.99% |
|
-38.99% |
|
-37.45% |
|
-38.99% |
|
$0.28 |
|
$-0.03 |
|
$-0.03 |
|